Joël
Drai
Founder & Chairman
MEGA BIOPHARMA
Advancing
bone regeneration.
MEGA BIOPHARMA develops a nacre-derived biomaterials platform for regenerative medicine in France. Through biomineralisation, materials science, formulation and industrial know-how, our teams connect scientific discovery, development and manufacturing.
Leadership
Our leadership team.
Joël
Didier
Bensadoun
CEO
Mickaël
Saada
COO
Engineer
Estelle
Collin
R&D Director
PhD
Pedro
Carvalho
Production & Industrialisation Director
Engineer
Laurène
Guion
Quality Manager
Master’s degree
Team
Research &
operations.
Research and development, regulatory affairs, production and human resources: expertise supporting our programmes.
Martin Lachaux
R&D Engineer · Regulatory Affairs Officer
Lisa Abdennebi
R&D Engineer
Suzanne De Vuyst
R&D Engineer · CIFRE student
Samantha Espierd
Production Operator
Mélanie Ferreira
HR Officer
Scientific advisers
Expertise that
connects.
Biomaterials, bone tissue and surgical practice: the committee brings together researchers, clinicians and healthcare entrepreneurs around our work.
Marthe Rousseau
A CNRS researcher working on biomaterials and interactions between nacre and bone tissue. She heads MEGA BIOPHARMA’s scientific committee.
Laurent Helewa
Trained as a dental surgeon, a medical-device entrepreneur and founder of Cleanis. He brings scientific and entrepreneurial perspectives to project development.
Marc Slama
A plastic surgeon with experience in reconstructive and maxillofacial surgery. He has held departmental leadership responsibilities at Hôtel-Dieu hospital in Paris.
Philippe Cottin
A surgeon with expertise in reconstructive surgery and a hospital background at Antoine-Béclère.
Daniel Chappard
A professor and researcher in bone remodelling and biomaterials. He led the GEROM laboratory at the University of Angers, dedicated to bone tissue research.
Thierry Madar
A dental surgeon practising periodontology, implantology and oral surgery. A former lecturer at Université Paris Cité.
Jacques Théron
A neuroradiologist and interventional radiologist, formerly a professor at Caen University Hospital. His work includes percutaneous approaches to the spine.
Robin Stephens
MTh, BSc, MIoD, FTOPRA, FRSC
CEO, Psephos Biomedica
An expert in clinical research, regulatory affairs and quality assurance for medical devices, he brings 40 years of experience. He founded Psephos Biomedica in 2001.
- Strategy & Commercialisation
Andrew Thompson
- Clinical Advisory Board Member
Laurent Corcos
Our ecosystem
An ecosystem
of experts.
Around our team, academic laboratories, testing specialists, industrial and commercial partners contribute to each stage of biomaterial development.
MEGA
BIOPHARMA
BIOPHARMA
Research · Development
Manufacturing
Academic research
- SainbioseBiomaterials · Marthe Rousseau
Sainbiose · Saint-Étienne
Exterior view of the building. - IMPMC · Sorbonne UniversitéIn vitro testing
- ICMPE · CNRS / UPECIn vitro testing
- PIMM · Arts et MétiersIn vitro testing
Preclinical assessment
Analysis & testing
Industrialisation & distribution
Skin research
Innovation support
MEGA Dental · Distribution
From research
to practitioners.
MEGA BIOPHARMA and MEGA Dental share the same founder, Joël Drai, and roots in the dental sector.
MEGA BIOPHARMA develops biomaterials. MEGA Dental, a distributor of dental products and equipment, contributes its understanding of dental practices and its distribution network in France.
This network will support the future distribution of Bionacre® Bone Graft, subject to the necessary authorisations.
Discover MEGA Dental ↗Within our entrepreneurial group, Blue Skincare develops an established dermo-cosmetic activity alongside our medical biomaterials programmes.
MEGA BIOPHARMA
A closer look
at our teams.
Our team, laboratories and nacre-processing expertise, in under a minute.
Let’s discuss your project